Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

MHH Researchers scrutinize EC Regulation

26.11.2010
500.000 Euros of funding for an assessment of regulatory impact on Advanced Therapies. GMP - Good Manufacturing Practice - defines a body of rules for pharmaceutical production.

A team of researchers from the United Kingdom, Sweden, Austria and Germany, with Professor Dr Martin Hildebrandt, Integrated Research and Treatment Center Transplantation (IFB-Tx), Hannover Medical School MHH) as coordinator, are setting up a platform for Academic GMP Institutions.

GMP - Good Manufacturing Practice - defines a body of rules for pharmaceutical production. Within the funded research project funded by the European Commission (EC):“The impact of Regulation (EC) No 1394/2007 on the development of Advanced Therapy Medicinal Products (ATMPs): an academic perspective“, the consequences of the EC Regulation on the academia as a significant source of novel and advanced therapeutics will be explored.

„We believe that the Regulation creates a disadvantage for the academic world which, in contrast to the industry, is not being fully taken into account by current EC legislation“, says Hildebrandt. The research team aims at an improvement of the so-called ATMP Regulation – for European citizens.

The project took off in September and receives a financial support of € 500.000 for thirty months. Just in time, i.e. prior to the finalization of the EC Regulation in December 2012, the results of the survey in European Academic Institutions will be presented as a targeted report on how the new ATMP regulations are impacting on the academic sector, with concrete suggestions to policy makers.

Advanced Therapy Medicinal Products (ATMPs) are medicinal products for human use, based on gene therapy, somatic cell therapy or tissue engineering. These therapeutics represent the ‘next generation’ of complex medicines for complex diseases. Regulation (EC) No 1394/2007 has been designed to ensure the free movement of these medicines within the European Union (EU), to facilitate their access to the EU market and to foster the competitiveness of European pharmaceutical companies in the field, while guaranteeing the highest level of health protection for patients.

Academic facilities are major contributors to the development of ATMPs. Not only do they have an important function in the translation of pre-clinical academic research into Good Manufacturing Practice, but some products may only reach clinical application by relying exclusively on academic facilities.The project will establish a common platform that brings together academic researchers, clinicians, quality managers, qualified persons, clinical trials coordinators, legal and regulatory advisors and regulators. „We hope to connect research participants and stakeholders and to foster dialogue that will ultimately benefit those in need of advanced therapies, to make a therapeutic advance“.

Further information is available at: academic-gmp@mh-hannover.de.

Stefan Zorn | idw
Further information:
http://www.mh-hannover.de/

More articles from Health and Medicine:

nachricht Another reason to exercise: Burning bone fat -- a key to better bone health
19.05.2017 | University of North Carolina Health Care

nachricht Disrupted fat breakdown in the brain makes mice dumb
19.05.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

Im Focus: World's thinnest hologram paves path to new 3-D world

Nano-hologram paves way for integration of 3-D holography into everyday electronics

An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...

Im Focus: Using graphene to create quantum bits

In the race to produce a quantum computer, a number of projects are seeking a way to create quantum bits -- or qubits -- that are stable, meaning they are not much affected by changes in their environment. This normally needs highly nonlinear non-dissipative elements capable of functioning at very low temperatures.

In pursuit of this goal, researchers at EPFL's Laboratory of Photonics and Quantum Measurements LPQM (STI/SB), have investigated a nonlinear graphene-based...

Im Focus: Bacteria harness the lotus effect to protect themselves

Biofilms: Researchers find the causes of water-repelling properties

Dental plaque and the viscous brown slime in drainpipes are two familiar examples of bacterial biofilms. Removing such bacterial depositions from surfaces is...

Im Focus: Hydrogen Bonds Directly Detected for the First Time

For the first time, scientists have succeeded in studying the strength of hydrogen bonds in a single molecule using an atomic force microscope. Researchers from the University of Basel’s Swiss Nanoscience Institute network have reported the results in the journal Science Advances.

Hydrogen is the most common element in the universe and is an integral part of almost all organic compounds. Molecules and sections of macromolecules are...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

Innovation 4.0: Shaping a humane fourth industrial revolution

17.05.2017 | Event News

Media accreditation opens for historic year at European Health Forum Gastein

16.05.2017 | Event News

 
Latest News

New approach to revolutionize the production of molecular hydrogen

22.05.2017 | Materials Sciences

Scientists enlist engineered protein to battle the MERS virus

22.05.2017 | Life Sciences

Experts explain origins of topographic relief on Earth, Mars and Titan

22.05.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>